Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 22

1651P - Comparison of surgical outcome and prognostic factors between pancreaticobiliary and intestinal types of periampullary adenocarcinoma following pancreaticoduodenectomy

Date

21 Oct 2023

Session

Poster session 22

Topics

Pathology/Molecular Biology;  Surgical Oncology

Tumour Site

Pancreatic Adenocarcinoma

Presenters

Saad Anwar

Citation

Annals of Oncology (2023) 34 (suppl_2): S895-S924. 10.1016/S0923-7534(23)01944-0

Authors

S. Anwar1, K. Parasar2, U. Anand3, B. Singh4

Author affiliations

  • 1 Surgical Gastroenterology, AIIMS - All India Institute of Medical Sciences - Patna, 801507 - Patna/IN
  • 2 Surgical Gastroenterology Department, All India Institute of Medical Sciences, 801105 - Patna/IN
  • 3 Surgical Gastroenterology, All India Institute of Medical Sciences, Patna, 801507 - Patna/IN
  • 4 Surgical Gastroenterology, All India institute of Medical Sciences, Patna, 801507 - Patna/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1651P

Background

The exact origin and associated prognosis of periampullary adenocarcinoma might be challenging to determine, especially in bulky tumours, due to the destruction of normal periampullary anatomy and the extension of the tumour beyond a single periampullary structure. Periampullary carcinomas are typically divided into pancreatobiliary and intestinal types according to histological differentiation. The aim of this study was to determine the prognostic value of this histological differentiation by comparing various clinic-pathological prognostic factors and surgical outcome in periampullary carcinoma cases that underwent pancreaticoduodenectomy.

Methods

From May 2018 to April 2021, 60 consecutive cases of periampullary carcinoma who underwent pancreaticoduodenectomy were included in this study. Cases were divided into two groups: pancreatobiliary and intestinal types. Various clinical and histopathological prognostic variables were analysed, and the association of these variables with pancreatobiliary and intestinal variants of periampullary carcinoma was determined using Chi-square and Fischer’s exact tests.

Results

20 cases were included in the pancreatobiliary group, and 40 cases were included in the intestinal group. These groups were comparable in terms of age, sex, nutritional status, and bilirubin levels. Pancreatobiliary type was more frequently associated with nodal disease (p<0.01), lymphovascular invasion (p<0.01) and perineural invasion (p=0.018). Post-operative morbidity was significantly higher in the pancreatobiliary group (p=0.043). Table: 1651P

S.No. Variable Periampullary Carcinoma x2 p-value
Pancreatobiliary Type Intestinal Type
1 Age (years) <60 15 32 0.196 0.658
>60 5 8
2 Sex Male 12 19 0.834 0.361
Female 8 21
3 Comorbidity Yes 6 16 0.574 0.449
No 24 24
4 Bilirubin (mg/dl) <5 8 8 2.73 0.099
>5 12 32
5 Albumin (g/dl) < 3 8 11 0.96 0.326
> 3 12 29
6 Pancreas Texture Firm 10 21 0.03 0.855
Soft 10 19
7 MPD <3mm 6 5 2.73 0.99
>3mm 14 35
8 Tumor size >2cm 8 21 0.834 0.361
<2cm 12 19
9 Nodal status Positive 12 10 7.03 0.008
Negative 8 30
10 Lymphovascular Invasion Present 12 9 8.24 0.004
Absent 8 31
11 Perineural Invasion Present 7 4 5.57 0.018
Absent 13 36
12 Grade 1 10 15 0.857 0.355
2/3 10 25
13 Post-operative Morbidity Yes 11 08 4.10 0.043
No 9 32

Conclusions

After pancreaticoduodenectomy, periampullary cancer of the pancreatobiliary type is linked to worse post-operative outcome and unfavourable histopathological prognostic markers. Therefore, after surgery, these cases should follow management algorithms with aggressive adjuvant therapy protocols.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.